Is There a Drop in Protection Rates for Vaccines Due to the Delta Variant of COVID-19?

There are emerging signs from Israel indicating that the Pfizer/BioNTech COVID-19 vaccine may not be as effective against the COVID-19 delta variant.

Although this is still a developing situation and will receive the attention of the entire world over the next few months as more information is collected, there are some key findings that have already been made regarding the efficacy of the Pfizer vaccine against the delta variant.

 

Israel’s Health Ministry have reported in the past that two shots of the Pfizer vaccine proved to provide a 93-95% protection rate against infection, hospitalization, and serious illness, with that number falling to just 64% since June 6 in infection cases.[1] This coincides with when social distancing measures were eased and when the delta variant began circling through the country.

 

Masks remain the most effective protection. One of the issues with masks, however, is landfills. The Avro Mask is unique — fully recyclable. Visit Avro Mask>>

Out of those infected with the new delta variant in Israel, approximately 55% occurred in individuals who had already received the vaccine, although this doesn’t mean that the vaccine is not doing its job. While the total number of new infections has certainly increased, indicating that the vaccine is not as effective against the delta variant, the rate of hospitalizations was not affected to the same degree. While previously, the vaccine had a success rate of 97% for preventing hospitalization of those infected with the virus, that number only fell by 4 points to 93%, showing that serious infections and hospitalizations had not spiked as much as new infections.[2]

Although it may not seem like a serious matter due to the minor rise in hospitalizations, a greater number of infections among vaccinated individuals may become a problem regarding the development of vaccine-resistant strains of the coronavirus[3]. The Israeli government is currently conducting further studies on infected individuals based on the hypothesis that the vaccine may potentially wear off over time in people of certain ages or with some pre-existing medical conditions, which comes as a shock since both the Pfizer and Moderna vaccines were originally reported to provide protection against the coronavirus for years.[4]

As of the time of writing, Pfizer has yet to release any type of statement regarding the effectiveness of their vaccine regarding the delta variant of the coronavirus in relation to events in Israel, while the Israeli government are reintroducing social distancing measures once more as their number of seriously ill people continues to increase.


NOTES

[1] EuroNews, “Israel sees drop in Pfizer vaccine protection against infections, still strong in severe illness”, May 7, 2021.  https://www.euronews.com/2021/07/05/us-health-coronavirus-israel-pfizer

[2] Bloomberg, “Pfizer Shot Halts Severe Illness in Israel as Delta  Spreads”, July 5, 2021. https://www.bloomberg.com/news/articles/2021-07-05/israel-sees-decline-in-pfizer-vaccine-efficacy-rate-ynet-says

[3] The New York Times, “Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds”, June 28, 2021. https://www.nytimes.com/2021/06/28/health/coronavirus-vaccines-immunity.html

[4] The New York Times, “Pfizer and Moderna Vaccines Likely to Produce Lasting Immunity, Study Finds”, June 28, 2021. https://www.nytimes.com/2021/06/28/health/coronavirus-vaccines-immunity.html

Did you miss this?

Other Popular Stories

  • Toyota Canada top producer for first time in 2015; RAV4 on a roar
  • Bombardier Challenger 350 set to fly with NetJets
  • Clean technologies for mining: Green Mining's time has come
  • Propellant leak during emergency abort sets back Boeing's spacecraft development for NASA
  • Oil supply rising even as demand growth falls; investment likely to be slashed further in 2017
  • Renewable energy use increased in US in 2012
  • Engineers Develop a Way to Recycle Single Wear PPE Facemasks into Road Materials
  • Bombardier Transportation workers ratify contract
  • Supply of oil at record highs, at 100 million barrels a day for the “first time ever”; expected to grow
  • Forest vertical cities in China: first forest city under construction covered in 1 million plants; produce 900 tons oxygen daily
  • Once more to the moon — NASA may use a commercial rocket to speed up the EM-1 moon mission planned for June 2020
  • Bombardier workers unite with company management in support of "battle" against U.S. based aerospace giant Boeing Co.
  • Within 10 years, almost 50 percent of retail jobs may disappear to automation
  • Breakthrough vehicles that dare to change the auto industry: 1300 hp EVs and 300 km ranges
  • Wind farm opponents' complaint lacked proof: judge
  • TransCanada's Energy East pipeline has building trades support
  • Solar Powered Cars — how practical is it; who is working on it; when is it coming? 5 companies profiled.
  • Propane suppliers condemn Ontario government's support of natural gas expansion
  • Hyundai Plans to Sell Millions of BEVs
  • 12 new electric vehicles by 2022 Renaut-Nissan-Mitsubishi alliance commits 30% of overall production output
Scroll to Top